| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247588C Adenosine A2A receptor antagonists |
| 03/29/2006 | CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 03/29/2006 | CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 03/29/2006 | CN1247584C I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives |
| 03/29/2006 | CN1247583C Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 03/29/2006 | CN1247582C Novel carbapenem compounds |
| 03/29/2006 | CN1247581C Processes for the preparation of carbapenem-type antibacterial agents |
| 03/29/2006 | CN1247578C Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 03/29/2006 | CN1247577C Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247574C Isoindolin-1-one glucokinase activators |
| 03/29/2006 | CN1247573C Method for preparing arylacetyl aminothiazole |
| 03/29/2006 | CN1247571C Novel 2H -pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |
| 03/29/2006 | CN1247570C Novel pyridyl cyanoguandine compounds |
| 03/29/2006 | CN1247569C Novel pyrimidyl sulfamide compounds with anti-tumor activity and their salts |
| 03/29/2006 | CN1247568C Novel urea compounds as vanilloid receptor antagonist for treatment of pains |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247564C Enrichment of ligusticum lactone and its preparations |
| 03/29/2006 | CN1247556C Process for producing dibenzothiazepine derivatives |
| 03/29/2006 | CN1247553C 2-imino-1,3-thiazine derivs. |
| 03/29/2006 | CN1247549C Benzotriazole compound and use thereof |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247538C Alkyl sulfonamide phenyl alkylamide compound and its prepn and medicinal use |
| 03/29/2006 | CN1247537C Process for preparation 3-aryl-2-hydroxypropionic acid derivative |
| 03/29/2006 | CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 03/29/2006 | CN1247527C 6-fluorobicyclo [3.1.0] hexame derivatives |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/29/2006 | CN1247491C Extraction process for total phenolic acid of salvia root and pharmacutical application thereof |
| 03/29/2006 | CN1247258C Combination therapy using anti-angiogenic agents and TNF alpha |
| 03/29/2006 | CN1247238C Chinese medicine ointment for curing hyperosteogeny, pain and numbness and its production method |
| 03/29/2006 | CN1247235C Chinese medicinal herb paste for treating traumatic injury |
| 03/29/2006 | CN1247227C External-use liposome prepn for treating mite-borne dermatosis |
| 03/29/2006 | CN1247223C Method for preparing greater celandine extract with anticancer action |
| 03/29/2006 | CN1247219C Medicine for treating piles |
| 03/29/2006 | CN1247216C External used Chinese medicinal ointment for scald and its preparation |
| 03/29/2006 | CN1247215C Medicine for treating mouth mucous ulcer |
| 03/29/2006 | CN1247204C Medicine for treating beri-beri |
| 03/29/2006 | CN1247203C Helicidum oral disintegation tablet and its preparing method |
| 03/29/2006 | CN1247202C Dioscin oral disintegration tablet and its preparing method |
| 03/29/2006 | CN1247201C Use of ribose to prevent cramping and soreness in muscles |
| 03/29/2006 | CN1247200C Cefonicid sodium antibacterial composition |
| 03/29/2006 | CN1247199C Nutrition supplement agent |
| 03/29/2006 | CN1247198C Composition for treating hyperlipemia |
| 03/29/2006 | CN1247197C Antibacterial combined medicine |
| 03/29/2006 | CN1247196C Solid prepn. of sodium vitamin C for injection and its prepn. method |
| 03/29/2006 | CN1247195C Silibinin oral disintegration tablet and its preparing method |
| 03/29/2006 | CN1247194C Nagelinai clathrate compound |
| 03/29/2006 | CN1247193C Eye drops |
| 03/29/2006 | CN1247192C Assay for identification of compound that promote meianin prodn. and retinoid-like compounds identified by said assay |
| 03/29/2006 | CN1247191C Hydroxy diphenyl ether compound |
| 03/29/2006 | CN1247190C Immediate release tablet cores of insoluble drugs having sustained release coating |
| 03/29/2006 | CN1247188C Medicinal composition |
| 03/29/2006 | CN1247182C Composition of component of skin whitening cosmetics |
| 03/28/2006 | USRE39050 Treating post-menopausal osteoporosis with raloxifene, formerly keoxifene, or raloxifene hydrochloride; new usage |
| 03/28/2006 | USRE39049 Methods for inhibiting bone loss |
| 03/28/2006 | US7019156 Complex derivatives of bis(2-acetylpyridinethiosemicarbazonato-N1,N2,S)gallium(III) as anticarcinogenic agents |
| 03/28/2006 | US7019149 Thromboxane ligands without blood clotting side effects |
| 03/28/2006 | US7019148 Synthesis of irbesartan |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019146 Ferrocene compound and use thereof |
| 03/28/2006 | US7019141 Quinolones with anti-HIV activity |
| 03/28/2006 | US7019139 Quinolinones and uses thereof |
| 03/28/2006 | US7019135 For therapy of viral infection |
| 03/28/2006 | US7019132 Porphyrin derivatives |
| 03/28/2006 | US7019125 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2006 | US7019122 Nucleic acid sequence comprises a series of genes in the order gag (group antigen), pol (polyprotein) where the pol sequence comprises an aspartic protease, an integrase and a reverse transcriptase/RNAseH. |
| 03/28/2006 | US7019108 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 03/28/2006 | US7019034 Compositions and methods for reducing serum glucose and triglyceride levels in diabetic mammals |
| 03/28/2006 | US7019033 For therapy of cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders |
| 03/28/2006 | US7019032 Agent for treating Parkinson's disease comprising astrocyte function-improving agent as active ingredient |
| 03/28/2006 | US7019031 By deactivation of the prenylation enzyme through covalent modification; method for screening for cancer drugs by ability to inhibit prenylation |
| 03/28/2006 | US7019030 Immunotherapeutic agents |
| 03/28/2006 | US7019029 Topically administering 3,4-dihydroxy,5-(phenylalkyl)-2,5-dihydrofuran-2-one derivatives of given formula; inhibits tyrosinase or tyrosine phosphatase |
| 03/28/2006 | US7019028 for producing a medicament, in particular for the treatment of allergic disorders, of asthmatic disorders, of inflammatory concomitant symptoms of asthma and/or of diseases which can be treated by inhibiting c-maf and NFAT |
| 03/28/2006 | US7019027 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019025 such as N-(4-{[methyl-(2-propynyl)amino]methyl}phenyl)-2-thiophenecarboximidamine; for inhibiting nitrogen oxide synthases and/or monoamine oxidases |
| 03/28/2006 | US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 03/28/2006 | US7019023 Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| 03/28/2006 | US7019022 such as ((1R)-6-fluoro-8-(methylsulfonyl)-9-{(1S)-1-[4-(trifluoromethyl)phenyl]ethyl}-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetic acid for treatment of prostaglandin D2 mediated diseases such as rhinitis, asthma and nasal congestion |
| 03/28/2006 | US7019021 such as 2-(6-bromo-3-dimethylamino-2-methylphenylimino)imidazolidine; stress |
| 03/28/2006 | US7019020 2-benzoxazolyl benzene derivatives and their use as UV screening agents |
| 03/28/2006 | US7019019 Matriptase inhibitors and methods of use |
| 03/28/2006 | US7019017 Small molecule inhibitors of HER2 expression |
| 03/28/2006 | US7019016 Therapy of sensorineural hearing loss in a mammal by administering NR2B subunit selective N-methyl-D-aspartate (NMDA) NR2B subtype receptor antagonist |
| 03/28/2006 | US7019014 Process for producing anticancer agent LL-D45042 |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019012 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/28/2006 | US7019011 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 03/28/2006 | US7019010 Combinations |
| 03/28/2006 | US7019009 Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
| 03/28/2006 | US7019008 Pyrrolidine sulfonamides |
| 03/28/2006 | US7019007 CCR-3 receptor antagonists (I) |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019005 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors |
| 03/28/2006 | US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor |